Pulse Biosciences (NASDAQ:PLSE) vs. WORK Medical Technology Group (NASDAQ:WOK) Head to Head Survey

WORK Medical Technology Group (NASDAQ:WOK) and Pulse Biosciences (NASDAQ:PLSE) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, analyst recommendations and institutional ownership.

Analyst Ratings

This is a summary of recent ratings and target prices for WORK Medical Technology Group and Pulse Biosciences, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
WORK Medical Technology Group	1	0	0	0	1.00
Pulse Biosciences	1	0	2	0	2.33

Pulse Biosciences has a consensus price target of $30.00, indicating a potential upside of 35.75%. Given Pulse Biosciences’ stronger consensus rating and higher possible upside, analysts plainly believe Pulse Biosciences is more favorable than WORK Medical Technology Group.

Risk and Volatility

WORK Medical Technology Group has a beta of 3.51, meaning that its stock price is 251% more volatile than the S&P 500. Comparatively, Pulse Biosciences has a beta of 1.74, meaning that its stock price is 74% more volatile than the S&P 500.

Institutional and Insider Ownership

77.0% of Pulse Biosciences shares are held by institutional investors. 74.6% of Pulse Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares WORK Medical Technology Group and Pulse Biosciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
WORK Medical Technology Group	N/A	N/A	N/A
Pulse Biosciences	N/A	-73.77%	-63.98%

Valuation & Earnings

This table compares WORK Medical Technology Group and Pulse Biosciences”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
WORK Medical Technology Group	$9.81 million	0.00	-$1.07 million	N/A	N/A
Pulse Biosciences	$350,000.00	4,293.08	-$72.78 million	($1.08)	-20.46

WORK Medical Technology Group has higher revenue and earnings than Pulse Biosciences.

Summary

Pulse Biosciences beats WORK Medical Technology Group on 6 of the 11 factors compared between the two stocks.

About WORK Medical Technology Group

WORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.

About Pulse Biosciences

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.